Clinical Trials Directory

Trials / Completed

CompletedNCT04625478

Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers

Summary

Different mechanisms have been proposed to explain the pathophysiology of chronic staphylococcal BJI, including biofilm formation and the ability of staphylococci to be internalized and to survive within cells. The intracellular localization of staphylococci is well documented by in vitro studies, however, few studies have shown the presence of intracellular staphylococci in clinical specimens from patients with BJI. The aim of the CRISBO study is to document the clinical relevance of intracellular staphylococci in the context of BJI. Immunostaining targeting staphylococci and components will be carried out on tissue samples taken from patients with BJI during their treatment (samples similar to those used for routine diagnosis in pathology). Our objectives are to identify whether intracellular staphylococci are observable in these samples and if so, in which cell type (s) are they housed.

Conditions

Interventions

TypeNameDescription
OTHERPatients having had an osteo-articular infection with StahylococcusImmunostaining targeting staphylococci and components will be performed on tissue samples collected from patients with osteo-articular infection

Timeline

Start date
2020-12-01
Primary completion
2021-09-20
Completion
2021-12-20
First posted
2020-11-12
Last updated
2025-12-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04625478. Inclusion in this directory is not an endorsement.